VGB-Ex01

N/A

Report date: 2025/08/11 17:53:15

Base Information

Drug NameVGB-Ex01
Drug Alias NameVGB-Ex01
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapyCell and gene therapy > Gene therapy > Gene editing > CRISPR > CRISPR-Cas12
Mechanisms of ActionStem cell replacementsHemoglobin subunit gamma-1 modulatorsHemoglobin subunit gamma-2 modulators
TargetsHemoglobin subunit gamma-1Hemoglobin subunit gamma-2
Therapy Area/Indicationsbeta-Thalassemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShanghai Vitalgen BioPharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Vitalgen BioPharma Co Ltd
Inactive CompaniesN/A
Active Indicationsbeta-Thalassemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A